Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Accendra Health's Enterprise Value is $2,079 Mil.
Accendra Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $3 Mil. Therefore, Accendra Health's EV-to-EBIT ratio for today is 826.25.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Accendra Health's Enterprise Value is $2,079 Mil.
Accendra Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $252 Mil. Therefore, Accendra Health's EV-to-EBITDA ratio for today is 8.24.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Accendra Health's Enterprise Value is $2,079 Mil.
Accendra Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $2,716 Mil. Therefore, Accendra Health's EV-to-Revenue ratio for today is 0.77.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Accendra Health's Enterprise Value is $2,079 Mil.
Accendra Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-335 Mil. Therefore, Accendra Health's EV-to-FCF ratio for today is -6.20.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Accendra Health (NYSE:ACH) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Accendra Health's current Enterprise Value is $2,079 Mil.
Accendra Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Accendra Health's current Enterprise Value is $2,079 Mil.
Accendra Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $252 Mil.
Accendra Health's current Enterprise Value is $2,079 Mil.
Accendra Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,716 Mil.
Accendra Health's current Enterprise Value is $2,079 Mil.
Accendra Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-117 Mil.
Accendra Health's current Enterprise Value is $2,079 Mil.
Accendra Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-335 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health Enterprise Value Related Terms
Accendra Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Accendra Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACH vs EDAP, YI, COSM: Enterprise Value Comparison
For the Medical Distribution subindustry, Accendra Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Accendra Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Accendra Health's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a Enterprise Value of $2,079 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Accendra Health and its competitors.
Is Accendra Health's Enterprise Value too high?
Accendra Health's current Enterprise Value is $2,079 Mil. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Enterprise Value compare to EDAP and YI?
Accendra Health's Enterprise Value of $2,079 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Accendra Health and its competitors. Accendra Health's current Enterprise Value is $2,079 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.20 — trading 36.3% below its estimated fair value. The current Enterprise Value is $2,079 Mil. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Accendra Health (ACH), the current Enterprise Value is $2,079 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.20 is trading 36.3% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Enterprise Value: $2,079 Mil
GF Value™: $5.02 vs. price of $3.20 (36.3% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
